GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Other Current Receivables

Abbisko Cayman (STU:8ZD) Other Current Receivables : €6.13 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Other Current Receivables?

Abbisko Cayman's Other Current Receivables for the quarter that ended in Dec. 2023 was €6.13 Mil.

Abbisko Cayman's quarterly Other Current Receivables declined from Dec. 2022 (€5.94 Mil) to Jun. 2023 (€5.82 Mil) but then increased from Jun. 2023 (€5.82 Mil) to Dec. 2023 (€6.13 Mil).

Abbisko Cayman's annual Other Current Receivables increased from Dec. 2021 (€3.68 Mil) to Dec. 2022 (€5.94 Mil) and increased from Dec. 2022 (€5.94 Mil) to Dec. 2023 (€6.13 Mil).


Abbisko Cayman Other Current Receivables Historical Data

The historical data trend for Abbisko Cayman's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Other Current Receivables Chart

Abbisko Cayman Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
0.22 1.15 3.68 5.94 6.13

Abbisko Cayman Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Receivables Get a 7-Day Free Trial 3.68 - 5.94 5.82 6.13

Abbisko Cayman Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Abbisko Cayman Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbisko Cayman (STU:8ZD) Business Description

Traded in Other Exchanges
Address
Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (STU:8ZD) Headlines

No Headlines